Today’s Kaiser Daily Health Policy Report says: "Some advocates have expressed concern over the commercial success of AARP-branded Medicare prescription drug plans." See the recent HealthBlawg post touching on the AARP Medicare Part D question as well.
David Harlow's Health Care Law Blog
Follow me on Twitter
;
ICYMI> Stephen Williams, CMO of SomaLogic, on the Promise of Proteomics — Harlow on Healthcare https://healthblawg.com/2023/01/stephen-williams-somalogic-proteomics.html?utm_source=twitter&utm_medium=social&utm_campaign=ReviveOldPost #digitalhealth #hcldr #HITsm
ICYMI> From EEGs to actionable clinical endpoints with Jacob Donoghue, MD PhD, CEO of Beacon Biosignals — Harlow on Healthcare https://healthblawg.com/2022/07/jacob-donoghue-beacon-biosignals.html?utm_source=twitter&utm_medium=social&utm_campaign=ReviveOldPost #digitalhealth #hcldr #HITsm
ICYMI> Lissy Hu, President of Connected Networks at WellSky — Harlow on Healthcare https://healthblawg.com/2023/01/lissy-hu-wellsky.html?utm_source=twitter&utm_medium=social&utm_campaign=ReviveOldPost #digitalhealth #hcldr #HITsm
HIPAAtools
The Walking Gallery
David Harlow
